“Invasive aspergillosis: Is treatment with "inexpensive" amphotericin B cost saving if ‘expensive’ voriconazole is only used on demand?”, Swiss Med Wkly, vol. 136, no. 3940, pp. 624–624, Oct. 2006, doi: 10.4414/smw.2006.11259.